Inventor · disambiguated record
William T. Windsor
Also filed as: WINDSOR WILLIAM T
13 granted patents·4 pending applications·151 citations·filing 1994–2010
90Inventor score
Top patents by PatentIndex Score
17 records- 0190US6451982B1Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5SCHERING CORP·Filed 2000·Granted Sep 17, 2002·35 cites·17 claims
- 0281US6056957AHumanized monoclonal antibodies against human interleukin-5SCHERING CORP·Filed 1994·Granted May 2, 2000·48 cites·30 claims
- 0376US7776589B1Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)SCHERING CORP·Filed 2007·Granted Aug 17, 2010·2 cites·8 claims
- 0476US6251583B1Peptide substrates for HCV NS3 protease assaysSCHERING CORP·Filed 1999·Granted Jun 26, 2001·45 cites·32 claims
- 0572US7067273B2Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the sameSCHERING CORP·Filed 2003·Granted Jun 27, 2006·3 cites·13 claims
- 0672US6645966B2Treatment of malaria with farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2002·Granted Nov 11, 2003·5 cites·9 claims
- 0769US7446195B2High affinity thiophene-based and furan-based kinase ligandsSCHERING CORP·Filed 2006·Granted Nov 4, 2008·1 cites·10 claims
- 0866US8034907B2Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptidesSCHERING CORP·Filed 2009·Granted Oct 11, 2011·0 cites·7 claims
- 0965US8088611B2Kinase domain polypeptide of human protein kinase B gamma (AKT3)PRONGAY ANDREW J·Filed 2010·Granted Jan 3, 2012·1 cites·5 claims
- 1058US7632920B2Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereofSCHERING CORP·Filed 2004·Granted Dec 15, 2009·0 cites·10 claims
- 1158US2006229249A1Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the sameSCHERING CORP·Filed 2006·Application pending·0 cites
- 1256US2011158944A1Braf biomarkersHOSTED THOMAS J·Filed 2008·Application pending·0 cites
- 1351US6539309B1Crystallizable farnesyl protein transferase compositions, crystals thereby obtained, and methods for useSCHERING CORP·Filed 1999·Granted Mar 25, 2003·8 cites·4 claims
- 1450US2004087592A1Treatment of malaria with farnesyl protein transferase inhibitorsFiled 2003·Application pending·0 cites
- 1548US7511063B2High affinity quinoline-based kinase ligandsSCHERING CORP·Filed 2006·Granted Mar 31, 2009·0 cites·51 claims
- 1648US2003134846A1Treatment of trypanosoma brucei with farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1737US6380172B1Monomeric lipophilic oligosaccharide antibiotic compositionsSCHERING CORP·Filed 1999·Granted Apr 30, 2002·3 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →